Transcelerate BioPharma Initiative 
In this 4-minute audio snippet, Roland Andersson, Director for Accenture’s Life Sciences R&D practice, and Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, discuss the Transcelerate Biopharma initiative, the goals of which are to increase compliance and the productivity of clinical trials.
Your browser does not support the audio element. Upgrade your browser to one that does
You can hear the full interview of Roland Andersson and Thomas Krohn and colleagues here:
Other resources:
